OxVax

company

About

OxVax focused on the development of an advanced next-generation dendritic cell vaccine platform for the treatment of solid tumor cancers.

Details

Last Funding Type
Seed
Industries
Biotechnology,Therapeutics
Founded date
Jan 1, 2021
Operating Status
Active

OXvax Ltd. is a spin-out company from the University of Oxford focused on the development of an advanced next-generation dendritic cell vaccine platform for the treatment of solid tumor cancers.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
OxVax has raised a total of — in funding over 2 rounds. Their latest funding was raised on Apr 21, 2021 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 21, 2021 Seed 2 Evotec
Lead Compass Investment
Detail

Investors

Number of Lead Investors
Number of Investors
2
2
OxVax is funded by 2 investors. Evotec and Lead Compass Investment are the most recent investors.
Investor Name Lead Investor Funding Round
Evotec Yes Seed
Lead Compass Investment Yes Seed